Stay updated on Pembrolizumab in Advanced Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedPublication source text was clarified to state that publications are automatically filled from PubMed and may not be about the study, and the Revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedRemoved the government funding and NIH operating status notice from the page. The core study details, eligibility criteria, and trial information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check47 days agoChange DetectedThe screenshots show the same study page with only minor formatting/layout adjustments and no changes to core details such as the study title, identifiers, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange Detected- Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check84 days agoChange DetectedUpdated to Revision: v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while keeping the revision label as the primary addition.SummaryDifference0.2%

- Check98 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.